AAAAAA
Results:
1-22
|
Results: 22
Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans
Authors:
Walsh, SL
Strain, EC
Abreu, ME
Bigelow, GE
Citation: Sl. Walsh et al., Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans, PSYCHOPHAR, 157(2), 2001, pp. 151-162
Authors:
Nann-Vernotica, E
Donny, EC
Bigelow, GE
Walsh, SL
Citation: E. Nann-vernotica et al., Repeated administration of the D-1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine, PSYCHOPHAR, 155(4), 2001, pp. 338-347
Authors:
Stoller, KB
Bigelow, GE
Walsh, SL
Strain, EC
Citation: Kb. Stoller et al., Effects of buprenorphine/naloxone in opioid-dependent humans, PSYCHOPHAR, 154(3), 2001, pp. 230-242
Authors:
Abreu, ME
Bigelow, GE
Fleisher, L
Walsh, SL
Citation: Me. Abreu et al., Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans, PSYCHOPHAR, 154(1), 2001, pp. 76-84
Authors:
Becker, AB
Strain, EC
Bigelow, GE
Stitzer, ML
Johnson, RE
Citation: Ab. Becker et al., Gradual dose taper following chronic buprenorphine, AM J ADDICT, 10(2), 2001, pp. 111-121
Authors:
Evans, SM
Walsh, SL
Levin, FR
Foltin, RW
Fischman, MW
Bigelow, GE
Citation: Sm. Evans et al., Effect of flupenthixol on subjective and cardiovascular responses to intravenous cocaine in humans, DRUG AL DEP, 64(3), 2001, pp. 271-283
Authors:
Lin, SN
Moody, DE
Bigelow, GE
Foltz, RL
Citation: Sn. Lin et al., A validated liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry method for quantitation of cocaine and benzoylecgonine in human plasma, J ANAL TOX, 25(7), 2001, pp. 497-503
Authors:
Johnson, RE
Strain, EC
Bigelow, GE
Citation: Re. Johnson et al., Treating opioid dependence. Reply, N ENG J MED, 344(7), 2001, pp. 530-531
Authors:
Walsh, SL
Geter-Douglas, B
Strain, EC
Bigelow, GE
Citation: Sl. Walsh et al., Enadoline and butorphanol: Evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans, J PHARM EXP, 299(1), 2001, pp. 147-158
Authors:
Walsh, SL
Haberny, KA
Bigelow, GE
Citation: Sl. Walsh et al., Modulation of intravenous cocaine effects by chronic oral cocaine in humans, PSYCHOPHAR, 150(4), 2000, pp. 361-373
Authors:
Strain, EC
Stoller, K
Walsh, SL
Bigelow, GE
Citation: Ec. Strain et al., Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers, PSYCHOPHAR, 148(4), 2000, pp. 374-383
Authors:
Robles, E
Silverman, K
Preston, KL
Cone, EJ
Katz, E
Bigelow, GE
Stitzer, ML
Citation: E. Robles et al., The brief abstinence test: voucher-based reinforcement of cocaine abstinence, DRUG AL DEP, 58(1-2), 2000, pp. 205-212
Authors:
Johnson, RE
Chutuape, MA
Strain, EC
Walsh, SL
Stitzer, ML
Bigelow, GE
Citation: Re. Johnson et al., A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence., N ENG J MED, 343(18), 2000, pp. 1290-1297
Authors:
Preston, KL
Bigelow, GE
Citation: Kl. Preston et Ge. Bigelow, Effects of agonist-antagonist opioids in humans trained in a hydromorphone/not hydromorphone discrimination, J PHARM EXP, 295(1), 2000, pp. 114-124
Authors:
Silverman, K
Chutuape, MA
Bigelow, GE
Stitzer, ML
Citation: K. Silverman et al., Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: effects of reinforcement magnitude, PSYCHOPHAR, 146(2), 1999, pp. 128-138
Authors:
Strain, EC
Bigelow, GE
Liebson, IA
Stitzer, ML
Citation: Ec. Strain et al., Moderate- vs high-dose methadone for opioid dependence - Reply, J AM MED A, 282(22), 1999, pp. 2122-2123
Authors:
Strain, EC
Bigelow, GE
Liebson, IA
Stitzer, ML
Citation: Ec. Strain et al., Moderate- vs high-dose methadone in the treatment of opioid dependence - Arandomized trial, J AM MED A, 281(11), 1999, pp. 1000-1005
Authors:
Bigelow, GE
Citation: Ge. Bigelow, 'Prometeo Equivocado', ESTRENO, 25(2), 1999, pp. 56-57
Authors:
Jones, HE
Bigelow, GE
Preston, KL
Citation: He. Jones et al., Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure, J PHARM EXP, 289(3), 1999, pp. 1350-1361
Authors:
Eissenberg, T
Stitzer, ML
Bigelow, GE
Buchhalter, AR
Walsh, SL
Citation: T. Eissenberg et al., Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions, J PHARM EXP, 289(2), 1999, pp. 936-945
Authors:
Stoller, KB
Bigelow, GE
Citation: Kb. Stoller et Ge. Bigelow, Regulatory, cost, and policy issues, METHADONE TREATMENT FOR OPIOID DEPENDENCE, 1999, pp. 15-37
Authors:
Preston, KL
Bigelow, GE
Citation: Kl. Preston et Ge. Bigelow, Opioid discrimination in humans: discriminative and subjective effects of progressively lower training dose, BEHAV PHARM, 9(7), 1998, pp. 533-543
Risultati:
1-22
|